NCT02806544View on ClinicalTrials.gov

Neoadjuvant Tamoxifen in Locally Advanced Breast Cancer in a Low/Middle Income Country

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Breast CancerBreast Neoplasms
Interventions
DRUG

Tamoxifen

Tamoxifen 20mg by mouth daily

All Listed Sponsors
collaborator

Washington University School of Medicine

OTHER

collaborator

Instituto National de Cancerologia, Guatemala

UNKNOWN

lead

Vanderbilt University

OTHER

NCT02806544 - Neoadjuvant Tamoxifen in Locally Advanced Breast Cancer in a Low/Middle Income Country | Biotech Hunter | Biotech Hunter